Skip to main content

Table 4 Assay results for the determination of added benzophenone in phenytoin pharmaceutical preparations

From: Derivative spectrophotometric analysis of benzophenone (as an impurity) in phenytoin

Dosage form

% Found(a) of Benzophenone(added)

 

Proposed method

Comparison method(13)

 

1D

3D

1DD

 

Phenytin® ampoules

099.80

099.25

101.05

099.60

 

101.00

099.63

099.25

100.98

 

099.95

098.33

100.19

098.98

Mean ( x ¯ ) ± S.D.

100.25 ± 0.65

099.07 ± 0.67

100.16 ± 0.90

099.85 ± 1.02

T

0.57

1.10

0.39

 

F

2.45

2.35

1.29

 

Phenytin® capsules

099.00

102.04

100.92

099.60

 

099.80

101.69

099.33

100.98

 

099.95

100.06

099.92

098.98

Mean ( x ¯ ) ± S.D.

099.58 ± 0.51

101.26 ± 1.05

100.06 ± 0.80

099.85 ± 1.02

T

0.41

1.66

0.27

 

F

4.02

1.07

1.62

 

Ipanten® capsules

100.10

101.59

101.15

099.60

 

099.10

100.06

100.01

100.98

 

099.90

099.65

099.86

098.98

Mean ( x ¯ ) ± S.D.

099.70 ± 0.53

100.43 ± 1.02

100.34 ± 0.71

099.85 ± 1.02

T

0.23

0.69

0.68

 

F

3.74

1.00

2.11

 
  1. a The average of three separate determinations.
  2. N.B. Tabulated t-value at P = 0.05 is 2.78, tabulated F-value at P = 0.05 is 19.00